Status:
COMPLETED
Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers
Lead Sponsor:
Central South University
Conditions:
Drug Interaction of Olmesartan in Healthy Chinese Volunteers
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
Hypertension and hyperuricaemia are widespread conditions. There is significant overlap between the two conditions. Serum uric acid (SUA) is currently recognized as a risk factor for cardiovascular di...
Detailed Description
Probenecid is a well-established hypouricaemic agent for the treatment of hyperuricaemia and gout and is thought to act on urate transporter 1 (URAT1), a novel member of the organic anion transporter ...
Eligibility Criteria
Inclusion
- written informed consent obtained,
- age 18 to 40 years and a body mass index between 19 and 25 kg/m2;
- negative test results for HIV and hepatitis В and C non-smoking status and
- an unremarkable clinical history
Exclusion
- has history or evidence of a renal, gastrointestinal, hepatic, or hematologic abnormality or
- any acute or chronic disease, or
- an allergy to any drugs
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01907373
Start Date
August 1 2009
End Date
October 1 2009
Last Update
July 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of New Drug Clinical Trial, Hunan Provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical School of Central South University)
Changsha, Hunan, China, 410006